BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16029036)

  • 1. Oxoazabenzo[de]anthracenes conjugated to amino acids: synthesis and evaluation as DNA-binding antitumor agents.
    Dias N; Goossens JF; Baldeyrou B; Lansiaux A; Colson P; Di Salvo A; Bernal J; Turnbull A; Mincher DJ; Bailly C
    Bioconjug Chem; 2005; 16(4):949-58. PubMed ID: 16029036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromophore-modified bisnaphthalimides: DNA recognition, topoisomerase inhibition, and cytotoxic properties of two mono- and bisfuronaphthalimides.
    Bailly C; Carrasco C; Joubert A; Bal C; Wattez N; Hildebrand MP; Lansiaux A; Colson P; Houssier C; Cacho M; Ramos A; Braña MF
    Biochemistry; 2003 Apr; 42(14):4136-50. PubMed ID: 12680768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities.
    Bailly C; Qu X; Chaires JB; Colson P; Houssier C; Ohkubo M; Nishimura S; Yoshinari T
    J Med Chem; 1999 Jul; 42(15):2927-35. PubMed ID: 10425102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel antitumor indenoindole derivatives targeting DNA and topoisomerase II.
    Bal C; Baldeyrou B; Moz F; Lansiaux A; Colson P; Kraus-Berthier L; Léonce S; Pierré A; Boussard MF; Rousseau A; Wierzbicki M; Bailly C
    Biochem Pharmacol; 2004 Nov; 68(10):1911-22. PubMed ID: 15476662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and cytotoxic activities of beta-carboline amino acid ester conjugates.
    Zhao M; Bi L; Wang W; Wang C; Baudy-Floc'h M; Ju J; Peng S
    Bioorg Med Chem; 2006 Oct; 14(20):6998-7010. PubMed ID: 16806943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligopyrrole carboxamides linked with a nucleobase as potential DNA minor groove binding ligands: synthesis, DNA binding and biological evaluation.
    Keuser C; Pindur U
    Pharmazie; 2006 Apr; 61(4):261-8. PubMed ID: 16649534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acenaphtho[1,2-b]pyrrole derivatives as new family of intercalators: various DNA binding geometry and interesting antitumor capacity.
    Zhang Z; Yang Y; Zhang D; Wang Y; Qian X; Liu F
    Bioorg Med Chem; 2006 Oct; 14(20):6962-70. PubMed ID: 16828559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor polycyclic acridines. Part 12. Physical and biological properties of 8,13-diethyl-6-methylquino[4,3,2-kl]acridinium iodide: a lead compound in anticancer drug design.
    Missailidis S; Stanslas J; Modi C; Ellis MJ; Robins RA; Laughton CA; Stevens MF
    Oncol Res; 2002; 13(3):175-89. PubMed ID: 12549627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and cytotoxic evaluation of a new series of 3-substituted spiro[(dihydropyrazine-2,5-dione)-6,3'-(2',3'-dihydrothieno[2,3-b]naphtho-4',9'-dione)] derivatives.
    Gomez-Monterrey I; Campiglia P; Carotenuto A; Califano D; Pisano C; Vesci L; Lama T; Bertamino A; Sala M; di Bosco AM; Grieco P; Novellino E
    J Med Chem; 2007 Apr; 50(8):1787-98. PubMed ID: 17375902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intercalation into DNA is not required for inhibition of topoisomerase I by indolocarbazole antitumor agents.
    Bailly C; Dassonneville L; Colson P; Houssier C; Fukasawa K; Nishimura S; Yoshinari T
    Cancer Res; 1999 Jun; 59(12):2853-60. PubMed ID: 10383146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antitumor evaluation of bis aza-anthracene-9,10-diones and bis aza-anthrapyrazole-6-ones.
    Antonini I; Santoni G; Lucciarini R; Amantini C; Dal Ben D; Volpini R; Cristalli G
    J Med Chem; 2008 Feb; 51(4):997-1006. PubMed ID: 18232651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amidine analogues of melphalan: synthesis, cytotoxic activity, and DNA binding properties.
    Bielawska A; Bielawski K; Anchim T
    Arch Pharm (Weinheim); 2007 May; 340(5):251-7. PubMed ID: 17458920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA binding properties of the indolocarbazole antitumor drug NB-506.
    Carrasco C; Vezin H; Wilson WD; Ren J; Chaires JB; Bailly C
    Anticancer Drug Des; 2001; 16(2-3):99-107. PubMed ID: 11962518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and topoisomerase poisoning activity of A-ring and E-ring substituted luotonin A derivatives.
    Nacro K; Zha CC; Guzzo PR; Jason Herr R; Peace D; Friedrich TD
    Bioorg Med Chem; 2007 Jun; 15(12):4237-46. PubMed ID: 17418582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.
    Strumberg D; Pommier Y; Paull K; Jayaraman M; Nagafuji P; Cushman M
    J Med Chem; 1999 Feb; 42(3):446-57. PubMed ID: 9986716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, DNA binding, and cytotoxicity of 1,4-bis(2-amino-ethylamino)anthraquinone-amino acid conjugates.
    Hsin LW; Wang HP; Kao PH; Lee O; Chen WR; Chen HW; Guh JH; Chan YL; His CP; Yang MS; Li TK; Lee CH
    Bioorg Med Chem; 2008 Jan; 16(2):1006-14. PubMed ID: 17962028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indeno[1,2-c]isoquinolin-5,11-diones conjugated to amino acids: Synthesis, cytotoxicity, DNA interaction, and topoisomerase II inhibition properties.
    Ahn G; Lansiaux A; Goossens JF; Bailly C; Baldeyrou B; Schifano-Faux N; Grandclaudon P; Couture A; Ryckebusch A
    Bioorg Med Chem; 2010 Nov; 18(22):8119-33. PubMed ID: 20961767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
    Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH
    Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity studies of novel amidine analogues of chlorambucil: correlation of cytotoxic activity with DNA-binding affinity and topoisomerase II inhibition.
    Bielawska A; Bielawski K; Wołczyński S; Anchim T
    Arch Pharm (Weinheim); 2003 Aug; 336(6-7):293-9. PubMed ID: 12953217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of N-methylmaleimide indolocarbazole bearing modified 2-acetamino acid moieties as Topoisomerase I inhibitors.
    Li Z; Zhai F; Zhao L; Guo Q; You Q
    Bioorg Med Chem Lett; 2009 Jan; 19(2):406-9. PubMed ID: 19058964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.